Newborn screening in mucopolysaccharidoses
Abstract Newborn screening (NBS) methods and therapeutic options have become increasingly available for mucopolysaccharidoses (MPS), and there is a clear evidence that early intervention significantly improves the outcome. It is recommended that mucopolysaccharidosis type I (MPS I) is included in th...
Saved in:
Main Authors: | Maria Alice Donati (Author), Elisabetta Pasquini (Author), Marco Spada (Author), Giulia Polo (Author), Alberto Burlina (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction to: Newborn screening in mucopolysaccharidoses
by: Maria Alice Donati, et al.
Published: (2019) -
Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
by: Jon Washburn, et al.
Published: (2020) -
ENT and mucopolysaccharidoses
by: Pier Marco Bianchi, et al.
Published: (2018) -
Orthopaedic challenges for mucopolysaccharidoses
by: Andrea Borgo, et al.
Published: (2018) -
Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
by: Alberto B. Burlina, et al.
Published: (2019)